Summary
Intracerebroventricularly administered neurotensin and [Gln4]-neurotensin (50–200 μg) increased the formation of Dopa in different brain regions of rats after inhibition of the aromatic l-amino acid decarboxylase. For both neuropeptides these increases were dose dependent (20–150%). In the corpus striatum [Gln4]-neurotensin was twice as active as neurotensin and it tended to be more active also in other brain regions. The brain tyrosine concentrations were also increased. [Gln4]-neurotensin (100–200 μg) following inhibition of the aromatic l-amino acid decarboxylase, increased the accumulation of 5-hydroxytryptophan in all brain regions by 30–60%. In contrast, neurotensin was completely inactive. In both cases the brain tryptophan concentrations were increased. Both neurotensin and [Gln4]-neurotensin also accelerated the disappearance of dopamine, noradrenaline and 5-hydroxytryptamine after inhibition of monoamine synthesis. These results show an increased brain monoamine turnover induced by both neuropeptides.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andén, N.-E., Fuxe, K., Hökfelt, T.: Effect of some drugs on central monoamine nerve terminals lacking nerve impulse flow. Eur. J. Pharmacol. 1, 226–232 (1967)
Andén, N.-E., Corrodi, H., Fuxe, K.: Turnover studies using synthesis inhibition. In: Metabolism of amines in the brain (G. Hooper, ed.), pp. 38–47. London: McMillan 1969
Atack, C. V.: The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay. Br. J. Pharmacol. 48, 699–714 (1973)
Atack, C., Lindqvist, M.: Conjoint native and orthophthaldialdehy-decondensate assays for the fluorimetric determination of 5-hydroxyindoles in brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 279, 267–84 (1973)
Atack, C., Magnusson, T.: A procedure for the isolation of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from the same sample using a single column of strongly acidic cation exchange resin. Acta Pharmacol. Toxicol. (Kbh.) 42, 35–57 (1978)
Bédard, P., Carlsson, A., Lindqvist, M.: Effect of a transverse cerebral hemisection on 5-hydroxytryptamine metabolism in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 272, 1–15 (1972)
Bertler, Å, Carlsson, A., Rosengren, E.: A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. Acta Physiol. Scand. 44, 273–292 (1958)
Bissette, G., Nemerolff, C. B., Loosen, P. T., Prange, A. J., Jr., Lipton, M. A.: Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin. Nature (Lond.) 262, 607–609 (1976)
Brown, M., Rivier, J., Vale, W.: Bombesin: potent effects on thermoregulation in the rat. Science 196, 998–1000 (1977)
Carlsson, A., Lindqvist, M.: Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo. J. Pharm. Pharmacol. 25, 437–440 (1973)
Carlsson, A., Lindqvist, M.: Dependence of 5-HT and catecholamine synthesis on precursor amino-acid levels in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 303, 157–164 (1978)
Carlsson, A., Davies, J. N., Kehr, W., Lindqvist, M., Atack, C. V.: Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Arch. Pharmacol. 275, 153–168 (1972)
Carlsson, A., García-Sevilla, J. A., Magnusson, T.: Effects of peptides on brain monoamines and gross behaviour. In: Principles for central regulation of the endocrine system. Nobel Symposium 42. Stockholm June 8–10, 1978 (K. Fuxe, T. Hökfelt, and R. Luft, eds.). New York: Plenum Press (in press, 1979)
Carraway, R., Leeman, S. E.: The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J. Biol. Chem. 248, 6854–6861 (1973)
Carraway, R. E., Leeman, S. E.: The amino acid sequence of a hypothalamic peptide, neurotensin. J. Biol. Chem. 250, 1907–1911 (1975a)
Carraway, R. E., Leeman, S. E.: The synthesis of neurotensin. J. Biol. Chem. 250, 1912–1918 (1975b)
Clineschmidt, B. V., McGuffin, J. C.: Neurotensin administered intracisternally inhibits responsiveness of mice to noxius stimuli. Eur. J. Pharmacol. 46, 395–396 (1977)
Folkers, K., Chang, D., Humphries, J., Carraway, R., Leeman, S. E., Bowers, C. Y.: Synthesis and activities of neurotensin, and its acid and amide analogs: Possible natural occurrence of [Gln4]-Neurotensin. Proc. Natl. Acad. Sci. U.S.A. 73, 3833–3837 (1976)
García-Sevilla, J. A., Ahtee, L., Magnusson, T., Carlsson, A.: Opiate-receptor mediated changes in monoamine synthesis in rat brain. J. Pharm. Pharmacol. 30, 613–621 (1978)
García-Sevilla, J. A., Magnusson, T., Carlsson, A.: Effect of intracerebroventricularly administered somatostatin on brain monoamine turnover. Brain Res. 155, 159–164 (1978)
Hökfelt, T., Elde, R., Johansson, O., Ljungdahl, Å., Schultzberg, M., Fuxe, K., Goldstein, M., Nilsson, G., Pernow, B., Terenius, L., Ganten, D., Jeffwate, S. L., Renfeld, L., Said, S.: Distribution of peptide-containing neurons. In: Psychopharmacology: A generation of progress. (M. A. Lipton, A. DiMascio, and K. F. Killam, eds.), pp. 39–66. New York: Raven Press 1978
Iversen, L. L., Iversen, S. D., Bloom, F., Douglas, C., Brown, M., Vale, W.: Calcium-dependent release of somatostatin and neurotensin from rat brain in vitro. Nature (Lond.) 273, 161–163 (1978)
Kehr, W., Carlsson, A., Lindqvist, M.: A method for the determination of 3,4-dihydroxyphenylalanine (Dopa) in brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 274, 273–280 (1972)
Kehr, W., Lindqvist, M., Carlsson, A.: Distribution of dopamine in the rat cerebral cortex. J. Neural Transm. 38, 173–180 (1976)
Kobayashi, R. M., Brown, M., Vale, W.: Regional distribution of neurotensin and somatostatin in rat brain. Brain Res. 126, 584–588 (1977)
Lazarus, C. H., Brown, M. R., Perrin, M. H.: Distribution, localization and characteristics of neurotensin binding sites in the brain. Neuropharmacology 16, 625–629 (1977)
Loosen, P. T., Nemeroff, C. B., Bissette, G., Burnett, G. B., Prange, A. J., Jr., Lipton, M. A.: Neurotensin-induced hypothermia in the rat: structure-activity studies. Neuropharmacology 17, 109–113 (1978)
Magnusson, T., Carlsson, A., Fisher, G. H., Chang, D., Folkers, K.: Effect of synthetic Substance P on monoaminergic mechanisms in brain. J. Neural Transm. 38, 89–93 (1976)
Nemeroff, C. B., Bissette, G., Prange, A. J., Jr., Loosen, P. T., Barlow, T. S., Lipton, M. A.: Neurotensin: central nervous system effects of a hypothalamic peptide. Brain Res. 128, 485–496 (1977)
Uhl, G. R., Snyder, S. H.: Regional and subcellular distribution of brain neurotensin. Life Sci. 19, 1827–1832 (1976)
Uhl, G. R., Snyder, S. H.: Neurotensin receptor binding, regional and subcellular distributions favor transmitter role. Eur. J. Pharmacol. 41, 89–91 (1977)
Waalkes, T. P., Udenfriend, S.: A fluorimetric method for the estimation of tyrosine in plasma and tissues. J. Lab. Clin. Med. 50, 733–736 (1957)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
García-Sevilla, J.A., Magnusson, T., Carlsson, A. et al. Neurotensin and its amide analogue [Gln4]-neurotensin: effects on brain monoamine turnover. Naunyn-Schmiedeberg's Arch. Pharmacol. 305, 213–218 (1978). https://doi.org/10.1007/BF00498813
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00498813